Premium
Fetal bone marrow as a source of stem cells for in utero or postnatal transplantation
Author(s) -
Golfier Fran´ois,
Bárcena Alicia,
Harrison Michael R.,
Muench Marcus O.
Publication year - 2000
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1046/j.1365-2141.2000.02009.x
Subject(s) - stem cell , cd34 , haematopoiesis , andrology , cd90 , progenitor cell , transplantation , biology , stem cell factor , cd38 , population , bone marrow , immunology , medicine , microbiology and biotechnology , environmental health
We examined the potential of human fetal bone marrow (FBM) as a source of haematopoietic stem cells for transplantation. The median number of cells obtained between 20 and 24 weeks' gestation was 1·9 × 10 9 and a median 1·17 × 10 8 of these cells expressed CD34. Flow cytometry was also used to estimate the content of three different candidate stem cell populations in the tissues older than 20 weeks' gestation. A median 8·8 × 10 5 CD34 ++ CD38 − cells, 1·37 × 10 6 CD34 ++ CD4 + cells and 2·20 × 10 6 CD34 ++ CD90 + cells were detected. The content of colony‐forming units culture (CFU‐C) in the FBM ranged from 2·8 × 10 4 to 6·0 × 10 6 per fetus. The CFU‐C content could be expanded 50‐fold by culture for 1 week in serum‐deprived medium and the growth factors kit ligand and granulocyte–macrophage colony‐stimulating factor. Positive selection of FBM CD34 +/++ cells was achieved using the Baxter Isolex 50 device. An average purity of 82% and yield of up to 19% of CD34 +/++ cells was achieved. T cells were depleted by 99·84%. Analysis of candidate stem cell populations and primitive CFU‐C suggested a preferential enrichment of these cells over the total population of CD34 +/++ cells. All FBM samples were found to be free of microbial contamination at the time of harvest and after selection of CD34 +/++ cells. Thus, FBM is a safe source of stem cells. The large number of progenitors and candidate stem cells that can be obtained from FBM makes it suitable for in utero and possibly postnatal transplantation.